je.st
news
Alkermes: Sale of 'non-core' CMO unit supports blossoming portfolio
2015-05-05 09:53:59| Biotech - Topix.net
Alkermes will continue to streamline its manufacturing and infrastructure to support a growing portfolio following the sale of its legacy CMO site. The sale of Alkermes' contract manufacturing facility in Gainesville, Georgia, to Recro Pharma was completed last month netting the pharma firm $50m and future royalties on meloxicam IV/IM.
Tags: sale
unit
supports
portfolio
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||